PDRN-Spermidine Nanoparticles Boost Skin Penetration and Reverse Aging Markers
Scientists fuse two regenerative compounds into nanoparticles that dramatically improve skin delivery and reduce key aging biomarkers.
Summary
Researchers from Beijing Technology and Business University engineered nanoparticles by combining polydeoxyribonucleotide (PDRN), a DNA-derived regenerative compound, with spermidine, a natural polyamine linked to autophagy and longevity. The resulting PDRN-NPs measured roughly 202 nm and overcame PDRN's poor skin penetration, achieving a 202% increase in lab-based skin permeability and 143% improvement in living tissue. The nanoparticles boosted mitochondrial ATP output by 46%, enhanced macrophage activity by 96%, reduced inflammatory markers TNF-α and IL-6, suppressed collagen-degrading MMP-1, and increased cell migration by 26%. Human skin trials confirmed structural and functional skin improvements, supporting the formulation's promise as an anti-aging cosmetic and regenerative medicine tool.
Detailed Summary
Skin aging involves collagen breakdown, chronic inflammation, reduced cellular energy, and impaired tissue regeneration. Two bioactive compounds—PDRN (a DNA fragment with regenerative properties) and spermidine (a polyamine that activates autophagy and scavenges free radicals)—have separately shown anti-aging potential, but PDRN's high negative charge and poor membrane permeability have limited its practical use in skincare and medicine.
This study innovatively combined PDRN and spermidine into stable nanoparticles (PDRN-NPs) averaging 201.9 nm in diameter. The electrostatic interaction between negatively charged PDRN and positively charged spermidine enabled self-assembly into uniform delivery vehicles, optimized through a systematic preparation and characterization process.
In cellular experiments, PDRN-NPs accumulated around fibroblasts, increased macrophage phagocytic capacity by 96%, and raised mitochondrial ATP expression by 46.14%—indicating enhanced cellular energy and immune function. The nanoparticles potently suppressed pro-inflammatory and pro-aging proteins TNF-α, IL-6, and MMP-1 (a key collagenase), while upregulating NRG1, a protein involved in tissue repair. Cell migration improved by 25.63%, critical for wound healing and skin renewal.
Penetration studies showed PDRN-NPs improved in vitro transdermal delivery by 202.3% and in vivo permeability by 143.4% compared to unformulated PDRN—a transformative gain for topical applications. Human efficacy evaluations confirmed measurable improvements in skin structure and function across multiple aging parameters.
The main caveat is that the human efficacy data are described only briefly in the abstract, limiting insight into trial size, duration, or controls. The technology also originates partly from a commercial entity (Beijing WeYep Innovation Technology), warranting independent replication. Still, the dual regenerative mechanism and dramatically improved delivery represent a meaningful advance for longevity-focused dermatology.
Key Findings
- PDRN-spermidine nanoparticles (~202 nm) increased in vitro skin permeability by 202% and in vivo permeability by 143%.
- Mitochondrial ATP expression rose 46% and macrophage phagocytic activity increased 96% in treated cells.
- Inflammatory markers TNF-α and IL-6, plus collagenase MMP-1, were significantly suppressed by PDRN-NPs.
- Cell migration improved by 25.63%, suggesting accelerated skin repair and regeneration.
- Human skin trials confirmed multi-level structural and functional anti-aging improvements.
Methodology
Researchers prepared PDRN-spermidine nanoparticles via electrostatic self-assembly and optimized the formulation through multi-dimensional physicochemical characterization. Efficacy was assessed in vitro using fibroblast and macrophage cell models, ex vivo skin permeation studies, and a human skin efficacy evaluation cohort.
Study Limitations
Human trial details (sample size, duration, controls) are not disclosed in the abstract, limiting assessment of clinical validity. Partial industry authorship (Beijing WeYep Innovation Technology) introduces potential conflicts of interest that call for independent replication. Long-term safety and stability data for the nanoparticles under real-world storage conditions are not addressed.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.
Enter your email to subscribe: